Dear Editor,

The true incidence of chronic myeloid leukemia (CML) in India is not available. According to 6 population-based cancer registries, the incidence of CML in India varies from 0.8 to 2.2/1,00,000 population for men and from 0.6 to 1.6/1,00,000 population for women.\[[@ref1]\] Hospital-based studies have reported a higher frequency of CML ranging from 40% to 82% of all cases of leukemia among adults.\[[@ref2]\]

A total of 68 patients diagnosed with CML were studied. Out of these, 36 were females and 32 males. The age range at presentation was 11--70 years of median age of 35 years at diagnosis. The maximum number of patients presented in the third decade (n-15) followed by four decade. Out of 68 patients, 39 (57%) presented in chronic phase (CP) at the time of diagnosis, 10 in accelerated and 19 in blast crisis (BC) \[[Table 1](#T1){ref-type="table"}\]. Fever was the most common symptom present in 27% of patients followed by abdominal fullness and pain (18%), bleeding manifestations (11%), bony pains (9%) and thrombotic events (6%). 9% patients were asymptomatic. On examination, moderate to massive splenomegaly was present in 34 (50%) patients whereas 6 (9%) patients in CP did not have a palpable spleen. Massive splenomegaly was found in 62% of patients in accelerated and BC as compared to 38% patients in CP. Also, patients in the younger age group had bigger spleens as compared to old (65% vs. 42%). 11 patients also had significant lymphadenopathy, most commonly involving the inguinal group.

###### 

Frequency of three phases of CML with age and gender distribution
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Hemoglobin (Hb) level was in the range of 5.5--13.0 g/dl (9.4 ± 4.8). Mean Hb levels did not differ much among the three phases \[[Table 2](#T2){ref-type="table"}\]. Average platelet count in younger group was significantly higher than in the older age group (mean 3.63 × 10^5^/µl ± 1.99 vs. 2.62 × 10^5^/µl ± 1.40; *P* = 0.01) \[[Table 2](#T2){ref-type="table"}\].
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Peripheral blood findings in patients according to phases
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Available data suggest that the epidemiology of CML is different in the Indian subcontinent and in other developing countries from that of the rest of the world.\[[@ref3]\] In our study, the median age was 35 years (range 11--70 years) which is significantly lower than reported in European\[[@ref4]\] (median age 55 years) and American literature\[[@ref5]\] (median age 66 years). In the study by Bhutani *et al*., the median age of onset is 38 years in India\[[@ref2]\] while in a regional study in Pakistan mean age was 37.87 years which is quite less than the age of presentation in west.\[[@ref6]\] Shorter life expectancy, under diagnosis in older people or a high prevalence of chronic infection in this population may be some of the reasons for younger age at presentation.\[[@ref7]\] The frequency of all three phases of CML that is, CP, accelerated phase and BC in our study was 57%, 15% and 28% respectively as compared to 96.8%, 2.2% and 0.9% respectively in a French study.\[[@ref3]\] The western literature describes bleeding manifestations to be more common in comparison to thrombotic events.\[[@ref7]\] There are significant differences in age and phases at presentation in comparison to west.
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